Jane Street Group, LLC Boston Scientific Corp Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 232,470 shares of BSX stock, worth $21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

232,470

Previous 318,082 26.92%

Holding current value

$21 Million

Previous $24.5 Million 20.47%

% of portfolio

0.0%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$72.96 - $84.0 $6.25 Million - $7.19 Million	-85,612 Reduced 26.92%	232,470 $19.5 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $3.35 Million - $3.87 Million	49,747 Added 18.54%	318,082 $24.5 Million
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $8.5 Million - $10.1 Million	-147,516 Reduced 35.47%	268,335 $18.4 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $8.34 Million - $9.91 Million	171,491 Added 70.18%	415,851 $24 Million
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $8.02 Million - $8.74 Million	-159,810 Reduced 39.54%	244,360 $12.9 Million
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $10.5 Million - $11.5 Million	210,997 Added 109.23%	404,170 $21.9 Million
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $2.35 Million - $2.6 Million	52,013 Added 36.85%	193,173 $9.66 Million
Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $7.65 Million - $9.13 Million	-193,373 Reduced 57.8%	141,160 $6.53 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $4.45 Million - $13.3 Million	121,247 Added 56.85%	334,533 $13 Million
Q2 2022 Aug 16, 2022	SELL	$35.24 - $47.1 $2.03 Million - $2.71 Million	-57,502 Reduced 21.24%	213,286 $7.95 Million
Q1 2022 May 17, 2022	BUY	$40.9 - $45.1 $657,263 - $724,757	16,070 Added 6.31%	270,788 $12 Million
Q4 2021 Feb 15, 2022	SELL	$38.07 - $44.87 $591,303 - $696,920	-15,532 Reduced 5.75%	254,718 $10.8 Million
Q3 2021 Nov 16, 2021	SELL	$41.23 - $45.88 $8.51 Million - $9.47 Million	-206,378 Reduced 43.3%	270,250 $11.7 Million
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $941,544 - $1.08 Million	-24,405 Reduced 4.87%	476,628 $20.4 Million
Q1 2021 May 18, 2021	SELL	$35.27 - $39.67 $20.8 Million - $23.4 Million	-589,655 Reduced 54.06%	501,033 $19.4 Million
Q4 2020 Feb 17, 2021	BUY	$33.15 - $41.97 $26.9 Million - $34.1 Million	812,739 Added 292.41%	1,090,688 $39.2 Million
Q3 2020 Nov 17, 2020	SELL	$34.44 - $42.23 $14.9 Million - $18.3 Million	-433,620 Reduced 60.94%	277,949 $10.6 Million
Q2 2020 Aug 17, 2020	BUY	$30.19 - $39.11 $16.1 Million - $20.8 Million	532,173 Added 296.65%	711,569 $25 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $2.53 Million - $4.48 Million	98,026 Added 120.47%	179,396 $5.85 Million
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $1.72 Million - $1.86 Million	42,745 Added 110.67%	81,370 $3.31 Million
Q2 2019 Aug 15, 2019	SELL	$34.91 - $42.98 $5.75 Million - $7.08 Million	-164,666 Reduced 81.0%	38,625 $1.66 Million
Q1 2019 May 16, 2019	BUY	$32.91 - $40.75 $5.6 Million - $6.93 Million	170,025 Added 511.11%	203,291 $7.8 Million
Q4 2018 Feb 15, 2019	BUY	$31.73 - $39.04 $44,517 - $54,773	1,403 Added 4.4%	33,266 $1.18 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $1.92 Million - $2.26 Million	-58,588 Reduced 64.77%	31,863 $1.23 Million
Q2 2018 Aug 15, 2018	BUY	$26.84 - $34.32 $2.22 Million - $2.84 Million	82,764 Added 1076.67%	90,451 $2.96 Million
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $1.43 Million - $1.62 Million	-56,680 Reduced 88.06%	7,687 $210,000
Q4 2017 Feb 15, 2018	BUY	$24.79 - $29.8 $1.11 Million - $1.33 Million	44,704 Added 227.35%	64,367 $1.6 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $516,350 - $573,569	19,663	19,663 $574,000

Others Institutions Holding BSX

# of Institutions

1,539

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Boston Scientific Corp Transaction History